当前位置: 首页 > 期刊 > 《中国新药杂志》 > 1998年第2期
编号:10645769
美洛西林治疗呼吸道感染54例
http://www.100md.com 《中国新药杂志》 1998年第2期
美洛西林|氨苄西林|呼吸道感染,关键词:
     郁引飞 张学云1 王晓薇2 (温州医学院附属二院,325027) 中国新药杂志 1998 0 0 2


    关键词:美洛西林;氨苄西林;呼吸道感染 期刊 zgxyzz 0 新药与临床 fur -->


    

摘要 目的: 评价美洛西林治疗呼吸道感染的临床疗效。方法: 治疗组54例呼吸道感染患者用美洛西林治疗(I组),对照组40例用氨苄西林治疗,剂量3.0~6.0g,bid,静脉滴注,疗程7~14d。结果: 治疗组和对照组临床总有效率分别为83.3%和62.5%;细菌培养阳性率分别为92.6%和90.0%,治疗后细菌转阴率分别为68.0%和44.4%,治疗期间未发现严重不良反应。结论: 美洛西林治疗呼吸道感染有较高的临床应用价值。

EFFICACY OF MEZLOCILLIN IN TREATMENT

    OF RESPIRATORY TRACT INFECTIONS IN 54 PATIENTS

    Yu Yinfei,Zhang Xueyun,Wang Xiaowei

    (The Second Hospital Affiliated to Wenzhou Medical College, 325027)



    ABSTRACT OBJECTIVE: To evaluate the efficacy of mezlocillin in treatmentof respiratory tract infections.METHODS: Group 1 consisted of 54 patientswith respiratory tract infections and they were treated with mezlocillin.Group 2 consistedof 40 patients and they were treated with ampicillin.RESULTS: The totaleffective rate was 83.3%in group 1 and was 62.5% in group 2.The positive rate in bacterialculture was 92.6% in group 1 and 90.0% in group 2. The bacterial eradication rate aftertreatment was 68.0% in group 1 and 44.4% in group 2. No obvious ADRs were observed duringtreatment in both groups.CONCLUSION: Mezlocillin is valuable in clinicaltreatment of respiratory tract infections.

     ......


您现在查看是摘要页,全文长 11117 字符